# Genewel breaks ground on $67M cGMP plant in Wonju, South Korea

Genewel Co., Ltd. held a groundbreaking ceremony for a new cGMP plant in Wonju, South Korea, with an investment of 50 billion won (approx. $67 million). The facility will produce wound dressings and other medical devices, consolidating existing plants in Seongnam and Hwaseong, and is expected to create 50 new jobs.

- Type: New facility
- Announced: 2025-05-29
- Where: Wonju, Gangwon Province, South Korea
- Value: $67.0M (50.0B KRW)
- Jobs: 50
- Status: under construction
- Products: wound dressings (Medifoam), anti-adhesion agents (Guardix), pain reduction drug delivery kits (Wellpass)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Genewel](https://endata.com/companies/78162.md)
- [Dongsung Chemical](https://endata.com/companies/78163.md) (partner)

## Sources

- [kwnews.co.kr](https://www.kwnews.co.kr/article/202505290044947), 2025-05-29: "Genewel is investing a total of 50 billion won to build a cGMP plant that meets US FDA standards."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.